Encouraging genomic testing is critical to identifying lung cancer patients who would benefit from targeted therapy.

Prior authorization is a process that is often criticized for denying care—but is actually designed to protect patients by ensuring they get the right care.

The advancements that will accelerate the delivery of proper treatment, reduce administrative burden, and improve the overall care experience for patients and providers.

Evernorth, Varian Lead Interoperability Efforts between Payers and Providers.